Andrew Bonwick
Vice President of Product Development at Relm Insurance
Madhav Sheth
CEO of Ai+ Smartphone
Stephen Rose
CEO Render Networks


The UK’s NHS is launching the world-leading trial of artificial intelligence (AI) to detect breast cancer earlier, which could lead to faster diagnosis of the disease. Nearly 700,000 women across the country will take part in a trial to test how cutting-edge AI tools can be used to catch breast cancer cases earlier, the Department of Health and Social Care announced on February 4, 2025.
Also Read: Google Cloud’s AI Helps Create Self-Healing Asphalt for Sustainable UK Roads
AI Trial for Early Breast Cancer Detection
To mark World Cancer Day on Monday, the Department of Health and Social Care (DHSC) announced the trial and confirmed that it is developing a new dedicated cancer plan to enhance diagnosis and treatment.
“Cutting-edge artificial intelligence trial to transform cancer care, helping radiologists catch breast cancer earlier,” the UK Government said, noting, “Thirty testing sites across the country will be enhanced with the digital AI technologies, ready to invite women already booked in for routine screenings on the NHS to take part in the trial.”
Also Read: European Union Says Its AI Investment Is Only 4 Percent Compared to US
EDITH Trial
The technology will assist radiologists in screening patients to identify changes in breast tissue that show possible signs of cancer and refer them for further investigations if required.
Currently, two specialists review each mammogram. If proved successful, this technology will enable one specialist to complete the same mammogram screening process. “If the trial is successful, it could free up hundreds of radiologists and other specialists across the country to see more patients, tackle rising cancer rates, save more lives and cut waiting lists,” the UK government said.